https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
5 years). In Dagestan, during analyzed period, life expectancy at birth increased more than on 5 years.The study was carried out to analyze detection of rare diseases that are not included into listings of rare (orphan) diseases to be treated at the expense of budget resources of the Russian Federation Russian Federation (hereinafter referred as rare diseases out of reimbursement). The analysis of detection of patients with rare diseases out of reimbursement in Russian Federation was carried out. The information was co
Curtir
Comentario
Compartilhar
